+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

JinkoSolar Holding Co Ltd (JKS) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 72 Pages
  • July 2026
  • GlobalData
  • ID: 3064206
JinkoSolar Holding Co Ltd (JKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

JinkoSolar Holding Co Ltd (JinkoSolar) is a manufacturer of solar products, focusing on a vertically integrated value chain that spans multiple stages of solar power product production. The company manufactures and sells a range of solar energy products, including silicon ingots and wafers, solar PV cells and modules, and both monocrystalline and multicrystalline photovoltaic panels. It also provides EPC solutions, technical support, and related solar system processing services. The company offers its products and services under the JinkoSolar brand. The company’s products find applications in furnaces, wire saws, automatic printers, laminating machines, injection molding machines, sandblasting machines, and junction box assembly machines, among others. The company's products serve a diverse global customer base, including utility-scale developers, project developers, EPC contractors, and distributed generation customers. It has a presence in Asia-Pacific, the Americas, the Middle East, and Africa. JinkoSolar is headquartered in Shangrao, Jiangxi, China.

JinkoSolar Holding Co Ltd Key Recent Developments

  • Jun 15, 2026: JinkoSolar Earns RETC's "Overall Highest Achiever" Award for the Seventh Consecutive Year
  • Jun 15, 2026: JinkoSolar Earns RETC Overall Highest Achiever Award for Seventh Consecutive Year
  • May 12, 2026: JinkoSolar, Masdar sign 2GW PV module supply agreement for RTC project
  • Apr 29, 2026: JinkoSolar Reports First Quarter 2026 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Venus Medtech Hangzhou Inc Company Overview
  • Venus Medtech Hangzhou Inc Company Snapshot
  • Venus Medtech Hangzhou Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Venus Medtech Hangzhou Inc - Pipeline Analysis Overview
  • Venus Medtech Hangzhou Inc - Key Facts
  • Venus Medtech Hangzhou Inc - Major Products and Services
  • Venus Medtech Hangzhou Inc Pipeline Products by Development Stage
  • Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status
  • Venus Medtech Hangzhou Inc Pipeline Products Overview
  • Cardiovalve
  • Cardiovalve Product Overview
  • Echomplish Device
  • Echomplish Device Product Overview
  • Limbus
  • Limbus Product Overview
  • Small Incision Surgical Valve
  • Small Incision Surgical Valve Product Overview
  • Transapical Trinity Aortic Valve Implantation System
  • Transapical Trinity Aortic Valve Implantation System Product Overview
  • Transfemoral Trinity Aortic Valve Implantation System
  • Transfemoral Trinity Aortic Valve Implantation System Product Overview
  • Tresillo System
  • Tresillo System Product Overview
  • Tumbao EndoVascular Aortic Repair System
  • Tumbao EndoVascular Aortic Repair System Product Overview
  • Venus PowerX Valve
  • Venus PowerX Valve Product Overview
  • Venus PowerX Valve Clinical Trial
  • Venus Vitae Valve
  • Venus Vitae Valve Product Overview
  • Venus Vitae Valve Clinical Trial
  • Venus-Neo
  • Venus-Neo Product Overview
  • Venus-Neo Clinical Trial
  • VenusP-Valve
  • VenusP-Valve Product Overview
  • VenusP-Valve Clinical Trial
  • Venus Medtech Hangzhou Inc - Key Competitors
  • Venus Medtech Hangzhou Inc - Key Employees
  • Venus Medtech Hangzhou Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
  • Recent Developments
  • Venus Medtech Hangzhou Inc, Recent Developments
  • Jul 28, 2026: Memorial Regional Hospital and Joe DiMaggio Children's Hospital Among First in the Nation to Implant Novel Pulmonary Valve for Patients with Congenital Heart Disease
  • Jul 24, 2026: Venus Medtech concludes patient enrolment for Venus-PowerX trial
  • Nov 17, 2025: Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion
  • Oct 24, 2025: Voluntary Announcement Completion of Full Patient Enrollment for Confirmatory Clinical Study of Cardiovalve TTVR
  • Aug 05, 2025: Court Sides With Cardiovalve in Edwards Patent Spat
  • Mar 28, 2025: Venus Medtech Announces Annual Results for Year Ended December 31, 2024
  • Sep 05, 2024: Two National Medical Device Standards Released with Venus Medtech’s Contribution
  • Sep 05, 2024: Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
  • Jun 30, 2024: Venusp-Valve Impresses at OCC-WCC 2024: Eight-Year Follow-up Data Affirms Long-Term Safety and Efficacy
  • Jun 17, 2024: Venus Medtech announces first implant of VenusP-Valve system in study
  • Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Venus Medtech Hangzhou Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Venus Medtech Hangzhou Inc Pipeline Products by Equipment Type
  • Venus Medtech Hangzhou Inc Pipeline Products by Indication
  • Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status
  • Venus Medtech Hangzhou Inc, Key Facts
  • Venus Medtech Hangzhou Inc, Major Products and Services
  • Venus Medtech Hangzhou Inc Number of Pipeline Products by Development Stage
  • Venus Medtech Hangzhou Inc Pipeline Products Summary by Development Stage
  • Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status
  • Venus Medtech Hangzhou Inc Ongoing Clinical Trials Summary
  • Cardiovalve - Product Status
  • Cardiovalve - Product Description
  • Echomplish Device - Product Status
  • Echomplish Device - Product Description
  • Limbus - Product Status
  • Limbus - Product Description
  • Small Incision Surgical Valve - Product Status
  • Small Incision Surgical Valve - Product Description
  • Transapical Trinity Aortic Valve Implantation System - Product Status
  • Transapical Trinity Aortic Valve Implantation System - Product Description
  • Transfemoral Trinity Aortic Valve Implantation System - Product Status
  • Transfemoral Trinity Aortic Valve Implantation System - Product Description
  • Tresillo System - Product Status
  • Tresillo System - Product Description
  • Tumbao EndoVascular Aortic Repair System - Product Status
  • Tumbao EndoVascular Aortic Repair System - Product Description
  • Venus PowerX Valve - Product Status
  • Venus PowerX Valve - Product Description
  • Venus PowerX Valve - Pivotal Study of Severe Aortic Stenosis Treated with the Venus-PowerX Transcatheter Aortic Valve System
  • Venus Vitae Valve - Product Status
  • Venus Vitae Valve - Product Description
  • Venus Vitae Valve - Multicenter Pivotal Study to Evaluate the Treatment of Severe Aortic Valve Stenosis With Next-Generation Venus-Vitae Transcatheter Heart Valve (THV) System
  • Venus-Neo - Product Status
  • Venus-Neo - Product Description
  • Venus-Neo - A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve
  • VenusP-Valve - Product Status
  • VenusP-Valve - Product Description
  • VenusP-Valve - A Real-World Evidence Observational Study of VenusP-ValveTM System in the Treatment of Patients with Native RVOT Dysfunction
  • VenusP-Valve - Evaluation of the Performance of the VenusP-ValveTM System in Patients with Native RVOT Dysfunction
  • VenusP-Valve - Implantation of the Venus P-Valve in the Pulmonic Position in Patients with Native Outflow Tracts
  • VenusP-Valve - Long-term Follow-up Study of Implantation of the VenusP-Valve in the Pulmonic Position in Patients With Native Outflow Tracts
  • Venus Medtech Hangzhou Inc, Key Employees
  • Venus Medtech Hangzhou Inc, Subsidiaries
  • Venus Medtech Hangzhou Inc, Joint Venture
  • Glossary
List of Figures
  • Venus Medtech Hangzhou Inc Pipeline Products by Equipment Type
  • Venus Medtech Hangzhou Inc Pipeline Products by Development Stage
  • Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status